Blog
RSS FeedPosted by Michael Wonder on 17 Feb 2022
COVID-19 vaccine weekly safety report (17 February 2022)
17 February 2022 - To 13 February 2022, the TGA has received 449 reports which have been assessed as likely to ...
Posted by Michael Wonder on 17 Feb 2022
Empaveli approved by the TGA
17 February 2022 - First TGA approval for newcomer Apellis. ...
Posted by Michael Wonder on 16 Feb 2022
Moderna's COVID-19 vaccine (Spikevax) provisionally approved for use in individuals 6 years and older
17 February 2022 - The TGA has provisionally approved the Moderna COVID-19 vaccine, Spikevax, for use in individuals aged 6 ...
Posted by Michael Wonder on 14 Feb 2022
Anxiety mounts for Australian patients as supply chain crunch hits another arthritis drug
14 February 2022 - Patients are reckoning with major shortages of a second rheumatoid arthritis drug in Australia, with manufacturing ...
Posted by Michael Wonder on 11 Feb 2022
New advice to keep Australians ‘up to date’ with COVID-19 vaccinations
10 February 2022 - The Australian Government has today received updated advice from the medical experts of the Australian Technical Advisory ...
Posted by Michael Wonder on 10 Feb 2022
Patent box legislation to promote Australian innovation
11 February 2022 - Medicines Australia notes the introduction of patent box legislation, Treasury Laws Amendment (Tax Concession for Australian ...
Posted by Michael Wonder on 10 Feb 2022
Three doses to be ‘up to date’ as national cabinet prepares for winter waves
10 February 2022 - Top Australian health officials now say people need a third coronavirus vaccine dose to be considered up ...
Posted by Michael Wonder on 10 Feb 2022
ATAGI update following weekly COVID-19 meeting – 9 February 2022
10 February 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 9 ...
Posted by Michael Wonder on 10 Feb 2022
COVID-19 vaccine weekly safety report (10 February 2022)
10 February 2022 - To 6 February 2022, the TGA has received 446 reports which have been assessed as likely to ...
Posted by Michael Wonder on 09 Feb 2022
TGA provisionally approves AstraZeneca's COVID-19 vaccine as booster dose
9 February 2022 - On 8 February 2022, the TGA provisionally approved a booster dose of the AstraZeneca COVID-19 vaccine, Vaxzevria, ...
Posted by Michael Wonder on 09 Feb 2022
Evolus receives acceptance of submission in Australia, a pivotal step in approval process for Nuceiva
8 February 2022 - Evolus today announced the acceptance of its submission to the Australian TGA for regulatory approval of Nuceiva ...
Posted by Michael Wonder on 08 Feb 2022
Three million Novavax doses touch down in Australia ahead of final TGA approval
8 February 2022 - Millions of Novavax vaccinations have arrived in Australia giving the country a new weapon against COVID-19. ...
Posted by Michael Wonder on 05 Feb 2022
TGA approves provisional determination for Gilead for COVID-19 treatment, Veklury (remdesivir), for proposed use in children and adults who are at risk of progressing to severe COVID-19
5 February 2022 - The TGA has granted a second provisional determination to Gilead in relation to its COVID-19 treatment, ...
Posted by Michael Wonder on 04 Feb 2022
To hell and back: devices meant to ease pain are causing trauma
5 February 2022 - A $35,000 treatment at the forefront of medical technology which pumps electric pulses into the spine ...
Posted by Michael Wonder on 03 Feb 2022
COVID-19 vaccine weekly safety report (3 February 2022)
3 January 2022 - To 30 January 2022, the TGA has received 440 reports which have been assessed as likely ...